GENTICEL
Genticel is a French clinical stage biotechnology company founded by Benedikt Timmerman in 2001 and focused on the development of innovative immunotherapies designed to treat virus infections and virus-induced diseases. Genticel aims to become a leader in immunotherapy in multiple indications, starting with HPV and HPV induced diseases such as cervical cancer.
GENTICEL
Social Links:
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2001-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.genticel.com
Total Employee:
11+
Status:
Closed
Contact:
+33 5 61 28 70 60
Total Funding:
41.38 M USD
Technology used in webpage:
Domain Not Resolving Adobe Dreamweaver
Current Employees Featured
Founder
Investors List
Andera Partners
Andera Partners investment in Series D - Genticel
InnoBio Fund
InnoBio Fund investment in Series D - Genticel
Idinvest Partners
Idinvest Partners investment in Series D - Genticel
Wellington Partners
Wellington Partners investment in Series D - Genticel
Amundi Private Equity Funds
Amundi Private Equity Funds investment in Series D - Genticel
Andera Partners
Andera Partners investment in Series C - Genticel
InnoBio Fund
InnoBio Fund investment in Series C - Genticel
Amundi Private Equity Funds
Amundi Private Equity Funds investment in Series C - Genticel
Idinvest Partners
Idinvest Partners investment in Series C - Genticel